In addition, silencing the ATG5 diminished tumor sphere formation and sensitized colorectal cancer cells to chemotherapeutic agents, suggesting that ATG5 could be a therapeutic target for colorectal cancer. This evidence concerns the gene ATG5 and colorectal cancer.